default search action

combined dblp search
author search
venue search
publication search

ask others

Igor Vorechovsky

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

Journal Articles

see FAQ

What is the meaning of the colors in the publication lists?

2011
[j3]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/nar/BurattiCHV11
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/nar/BurattiCHV11
Emanuele Buratti, Martin Chivers, Gyulin Hwang, Igor Vorechovsky:
DBASS3 and DBASS5: databases of aberrant 3′- and 5′-splice sites. Nucleic Acids Res. 39(Database-Issue): 86-91 (2011)
2010
[j2]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/bmcbi/ChurbanovVH10
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcbi/ChurbanovVH10
Alexander G. Churbanov, Igor Vorechovsky, Chindo Hicks:
A method of predicting changes in human gene splicing induced by genetic variants in context of cis-acting elements. BMC Bioinform. 11: 22 (2010)
1996
[j1]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/nar/VihinenIKKOVS96
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/nar/VihinenIKKOVS96
Mauno Vihinen, Tsutomu Iwata, Christine Kinnon, Sau-Ping Kwan, Hans D. Ochs, Igor Vorechovsky, C. I. Edvard Smith:
BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res. 24(1): 160-165 (1996)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.